Quince Therapeutics
QNCX
QNCX
91 hedge funds and large institutions have $673M invested in Quince Therapeutics in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 28 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3.51% more ownership
Funds ownership: 59.85% → 63.37% (+3.5%)
4% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 28
8% less call options, than puts
Call options by funds: $16.2M | Put options by funds: $17.6M
Holders
91
Holding in Top 10
2
Calls
$16.2M
Puts
$17.6M
Top Buyers
| 1 | +$25.8M | |
| 2 | +$8.69M | |
| 3 | +$5.36M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.01M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.89M |
Top Sellers
| 1 | -$5.05M | |
| 2 | -$4.28M | |
| 3 | -$3.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.75M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$1.48M |